Articles Tagged with ''Center for Veterinary Medicine''

The Food and Drug Administration will use an outside evaluation released Tuesday to help reform its human foods program, FDA Commissioner Robert Califf said following release of the report by the Reagan-Udall Foundation.

Is a seaweed feed additive which can significantly reduce methane emissions considered a feed ingredient or animal drug? What about an animal food ingredient which could actually reduce the risk of salmonella? According to current Food and Drug Administration policy, the answer is an animal drug, adding years and additional cost to gain approval from FDA.

Panel members appointed to evaluate the Food and Drug Administration’s human foods programs have their work cut out for them as they craft recommendations for FDA leadership.

The Food and Drug Administration has for the first time approved an intentional genomic alteration, or IGA, in animals that can be used for both food and human therapeutics.

The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, but the industry is backing the Agriculture Department's push to take over some of FDA's oversight role.

Dana O’Brien is the executive vice president of food & agriculture at Biotechnology Innovation Organization (BIO) and in this piece he shares his thoughts on improving the regulatory system for animal biotechnology.

Bringing all medically important antimicrobial drugs approved for use in animals under veterinary oversight and promoting proper stewardship of antimicrobials are among the goals of a five-year plan released by the Food and Drug Administration’s Center for Veterinary Medicine on Friday.